Meeting
2019 Genitourinary Cancers Symposium
Patient perspectives on cytoreductive nephrectomy after CARMENA.
Authors
Dena Battle
KCCure, Alexandria, VA
Dena Battle , Daniel J. George , Axel Bex , Michael D. Staehler
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 658)
DOI
10.1200/JCO.2019.37.7_suppl.658
Abstract #
658
Poster Bd #
J11
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Meta-analysis of upfront VEGF targeted therapy prior to nephrectomy in metastatic clear cell renal cancer.
First Author: Akhila Ganeshi Wimalasingham
Poster
2023 ASCO Genitourinary Cancers Symposium
Impact of cytoreductive nephrectomy (CRN) on overall survival (OS) in metastatic non–clear cell renal cancer (nccRCC).
First Author: Ariel Ann Nelson
Poster
2020 Genitourinary Cancers Symposium
Differences in the exposure to sunitinib in the immediate and deferred cytoreductive nephrectomy (CN) arms of the randomized controlled trial SURTIME.
First Author: Yasmin Abu-Ghanem
Poster
2020 Genitourinary Cancers Symposium
Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).
First Author: Aly-Khan A. Lalani